Alliance Pharma share price forecast is up after its FY 2024 results
Alliance Pharma’s share price LON:APH is up +0.16% after its FY 2024 results showed a mixed performance among the firm’s varied product lines. AIM-listed Alliance Pharma’s latest earnings suggest that the company is transitioning its business against a complex market backdrop. The headline numbers don’t look that good, with revenues dipping to £180.3m, from £182.7m
Alliance Pharma share price forecast is up after its FY 2024 results Read More »